Home » Topics » BioWorld Science

BioWorld Science
RSS

Novavax seeks approval of Estrasorb in U.S.; expands license agreement with King

July 3, 2001

New AGE production inhibitor with promise in diabetic nephropathy

July 3, 2001

CollaGenex launches tablet formulation of Periostat

July 3, 2001

Small-molecule LFA-1 antagonist enters phase I studies

July 3, 2001

Org-25935 dose-dependently increases striatal glycine levels in rats

July 3, 2001

ADA news: glycemic control and lipid profiles improve on INS-1 + sulfonylurea in type 2 diabetes

July 3, 2001

Roche licenses levovirin from ICN

July 3, 2001

SafeScience to create joint venture with Elan for phase II anticancer agent

July 3, 2001

Exclusivity period for human gene therapeutic consortium expires

July 3, 2001

Metabolex/Pfizer diabetes partnership gains new focus

July 3, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...